Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1167P is a pseudogene annotated as "RNA, U6 small nuclear 1167, pseudogene." Pseudogenes are genomic sequences similar to known genes but are nonfunctional due to mutations or truncation. The parental functional gene here is the U6 small nuclear RNA gene, which encodes U6 snRNA, a crucial RNA component of the spliceosome involved in pre-mRNA splicing[1][2][3]. However, RNU6-1167P does not encode a functional snRNA and does not participate in canonical biological processes such as splicing. It is one of many pseudogenes in the human genome derived from retrotransposition events involving the U6 snRNA, and its presence marks past genetic activity but does not have an active or therapeutic molecular role[2][4]. No; pseudogenes like RNU6-1167P are generally not considered therapeutic targets, receptors, enzymes, transporters, or entities involved in disease processes or drug interactions[2][4]. There is no evidence for biological activity or disease relevance of RNU6-1167P, nor are there known drugs, biomarkers, mechanisms, or safety concerns associated with it. Yes; "RNU6-1167P" is not a target in the conventional sense (receptor, enzyme, transporter, etc.), but a noncoding pseudogene. Queries about its role as a therapeutic target or receptor are therefore incorrect or misleading[2][4]. RNU6-1167P is a nonfunctional pseudogene related to the U6 snRNA gene, with no known biological, therapeutic, or diagnostic significance and should not be confused with functional targets or receptors[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1167, pseudogene (RNU6-1167P).